CSPC Zhongrun
Hebei Zhongrun Pharmaceutical Co., Ltd (CSPC Zhongrun) (simplified Chinese: 石è¯é›†å›¢æ²³åŒ—ä¸æ¶¦åˆ¶è¯æœ‰é™å…¬å¸; traditional Chinese: 石藥集團河北ä¸æ½¤åˆ¶è—¥æœ‰é™å…¬å¸; pinyin: ShÃyà o jÃtuán hébÄ›i zhÅngrùn zhìyà o yÇ’uxià n gÅngsÄ«) is one of China's largest producers of bulk antibiotic active pharmaceutical ingredients. CSPC Zhongrun produces both penicillin and cephalosporin series API.
A joint venture established in 1989 by China Pharmaceutical Group Ltd (CHINA PHARMA HKEx 01093) , CSPC Zhongrun employs more than 3,600 workers.
CSPC Zhongrun penicillin and cephalosporin Beta-lactam antibiotic products include 16 varieties of API and intermediates. The penicillin series includes penicillin G potassium crude, penicillin G potassium, penicillin G sodium, 6-APA, amoxicillin trihydrate, ampicillin trihydrate and ampicillin sodium.
The cephalosporin series includes intermediate 7-ACA, cefazolin sodium, cefazolin acid and ceftriaxone sodium. Meropenem API is also produced.
External links
- CSPC Zhongrun (English)